3,119 research outputs found
Recommended from our members
Glaucomatous vertical vessel density asymmetry of the temporal raphe detected with optical coherence tomography angiography.
Changes in retinal vasculature and ocular circulation may play an important role in the glaucoma development and progression. We evaluated the vertical asymmetry across the temporal raphe of the deep retinal layer vessel density, using swept-source optical coherence tomography angiography (SS-OCTA), and its relationship with the central visual field (VF) loss. Thirty-four eyes of 27 patients with open-angle glaucoma were included. SS-OCTA macular scanning was performed within a 3 × 3 mm (300 × 300 pixels) volume, centred on the fovea. The relationships between the vertical asymmetrical deep retinal vessel density reduction (ADRVD) across the temporal raphe and various ocular parameters were analysed. Twenty-two glaucomatous eyes with ADRVDs had central VF loss. Contrarily, ADRVDs were not found in any of the 12 eyes without central VF loss. Thirteen eyes (59.1%) with central VF loss had ADRVDs topographically corresponding to the central VF loss and macular ganglion cell complex thinning. The glaucomatous eyes with ADRVDs exhibited inferior rather than superior central VF loss (P = 0.032). Thus, ADRVD specifically indicates the glaucomatous central visual loss. Further analysis of ADRVD may improve our understanding on glaucoma pathogenesis, offering new treatment insights
Three-Dimensional Spectral-Domain Optical Coherence Tomography Data Analysis for Glaucoma Detection
Purpose: To develop a new three-dimensional (3D) spectral-domain optical coherence tomography (SD-OCT) data analysis method using a machine learning technique based on variable-size super pixel segmentation that efficiently utilizes full 3D dataset to improve the discrimination between early glaucomatous and healthy eyes. Methods: 192 eyes of 96 subjects (44 healthy, 59 glaucoma suspect and 89 glaucomatous eyes) were scanned with SD-OCT. Each SD-OCT cube dataset was first converted into 2D feature map based on retinal nerve fiber layer (RNFL) segmentation and then divided into various number of super pixels. Unlike the conventional super pixel having a fixed number of points, this newly developed variable-size super pixel is defined as a cluster of homogeneous adjacent pixels with variable size, shape and number. Features of super pixel map were extracted and used as inputs to machine classifier (LogitBoost adaptive boosting) to automatically identify diseased eyes. For discriminating performance assessment, area under the curve (AUC) of the receiver operating characteristics of the machine classifier outputs were compared with the conventional circumpapillary RNFL (cpRNFL) thickness measurements. Results: The super pixel analysis showed statistically significantly higher AUC than the cpRNFL (0.855 vs. 0.707, respectively, p = 0.031, Jackknife test) when glaucoma suspects were discriminated from healthy, while no significant difference was found when confirmed glaucoma eyes were discriminated from healthy eyes. Conclusions: A novel 3D OCT analysis technique performed at least as well as the cpRNFL in glaucoma discrimination and even better at glaucoma suspect discrimination. This new method has the potential to improve early detection of glaucomatous damage. © 2013 Xu et al
Serial optical coherence microscopy for label-free volumetric histopathology
The observation of histopathology using optical microscope is an essential procedure for examination of tissue biopsies or surgically excised specimens in biological and clinical laboratories. However, slide-based microscopic pathology is not suitable for visualizing the large-scale tissue and native 3D organ structure due to its sampling limitation and shallow imaging depth. Here, we demonstrate serial optical coherence microscopy (SOCM) technique that offers label-free, high-throughput, and large-volume imaging of ex vivo mouse organs. A 3D histopathology of whole mouse brain and kidney including blood vessel structure is reconstructed by deep tissue optical imaging in serial sectioning techniques. Our results demonstrate that SOCM has unique advantages as it can visualize both native 3D structures and quantitative regional volume without introduction of any contrast agents
Stent implant follow-up in intravascular optical coherence tomography images
The objectives of this article are (i) to
utilize computer methods in detection of stent struts
imaged in vivo by optical coherence tomography
(OCT) during percutaneous coronary interventions
(PCI); (ii) to provide measurements for the assessment
and monitoring of in-stent restenosis by OCT post PCI.
Thirty-nine OCT cross-sections from seven pullbacks
from seven patients presenting varying degrees of
neointimal hyperplasia (NIH) are selected, and stent
struts are detected. Stent and lumen boundaries are
reconstructed and one experienced observer analyzed
the strut detection, the lumen and stent area measurements,
as well as the NIH thickness in comparison to
manual tracing using the reviewing software provided
by the OCT manufacturer (LightLab Imaging, MA,
USA). Very good agreements were found between
the computer methods and the expert evaluations
for lumen cross-section area (mean difference =
0.11 ± 0.70 mm2; r2 = 0.98, P\ 0.0001) and the
stent cross-section area (mean difference = 0.10 ±
1.28 mm2; r2 = 0.85, P value\ 0.0001). The average
number of detected struts was 10.4 ± 2.9 per crosssection
when the expert identified 10.5 ± 2.8
(r2 = 0.78, P value\0.0001). For the given patient
dataset: lumen cross-sectional area was on the average
(6.05 ± 1.87 mm2), stent cross-sectional area was
(6.26 ± 1.63 mm2), maximum angle between struts
was on the average (85.96 ± 54.23), maximum,
average, and minimum distance between the stent
and the lumen were (0.18 ± 0.13 mm), (0.08 ±
0.06 mm), and (0.01 ± 0.02 mm), respectively, and
stent eccentricity was (0.80 ± 0.08). Low variability
between the expert and automatic method was
observed in the computations of the most important
parameters assessing the degree of neointimal tissue
growth in stents imaged by OCT pullbacks. After
further extensive validation, the presented methods
might offer a robust automated tool that will improve
the evaluation and follow-up monitoring of in-stent
restenosis in patients
Supervised machine learning based multi-task artificial intelligence classification of retinopathies
Artificial intelligence (AI) classification holds promise as a novel and
affordable screening tool for clinical management of ocular diseases. Rural and
underserved areas, which suffer from lack of access to experienced
ophthalmologists may particularly benefit from this technology. Quantitative
optical coherence tomography angiography (OCTA) imaging provides excellent
capability to identify subtle vascular distortions, which are useful for
classifying retinovascular diseases. However, application of AI for
differentiation and classification of multiple eye diseases is not yet
established. In this study, we demonstrate supervised machine learning based
multi-task OCTA classification. We sought 1) to differentiate normal from
diseased ocular conditions, 2) to differentiate different ocular disease
conditions from each other, and 3) to stage the severity of each ocular
condition. Quantitative OCTA features, including blood vessel tortuosity (BVT),
blood vascular caliber (BVC), vessel perimeter index (VPI), blood vessel
density (BVD), foveal avascular zone (FAZ) area (FAZ-A), and FAZ contour
irregularity (FAZ-CI) were fully automatically extracted from the OCTA images.
A stepwise backward elimination approach was employed to identify sensitive
OCTA features and optimal-feature-combinations for the multi-task
classification. For proof-of-concept demonstration, diabetic retinopathy (DR)
and sickle cell retinopathy (SCR) were used to validate the supervised machine
leaning classifier. The presented AI classification methodology is applicable
and can be readily extended to other ocular diseases, holding promise to enable
a mass-screening platform for clinical deployment and telemedicine.Comment: Supplemental material attached at the en
Volumetric microvascular imaging of human retina using optical coherence tomography with a novel motion contrast technique
Phase variance-based motion contrast imaging is demonstrated using a spectral domain optical coherence tomography system for the in vivo human retina. This contrast technique spatially identifies locations of motion within the retina primarily associated with vasculature. Histogram-based noise analysis of the motion contrast images was used to reduce the motion noise created by transverse eye motion. En face summation images created from the 3D motion contrast data are presented with segmentation of selected retinal layers to provide non-invasive vascular visualization comparable to currently used invasive angiographic imaging. This motion contrast technique has demonstrated the ability to visualize resolution-limited vasculature independent of vessel orientation and flow velocity
A New 3-D automated computational method to evaluate in-stent neointimal hyperplasia in in-vivo intravascular optical coherence tomography pullbacks
Abstract. Detection of stent struts imaged in vivo by optical coherence
tomography (OCT) after percutaneous coronary interventions (PCI) and
quantification of in-stent neointimal hyperplasia (NIH) are important.
In this paper, we present a new computational method to facilitate the
physician in this endeavor to assess and compare new (drug-eluting)
stents. We developed a new algorithm for stent strut detection and utilized
splines to reconstruct the lumen and stent boundaries which provide
automatic measurements of NIH thickness, lumen and stent area. Our
original approach is based on the detection of stent struts unique characteristics:
bright reflection and shadow behind. Furthermore, we present
for the first time to our knowledge a rotation correction method applied
across OCT cross-section images for 3D reconstruction and visualization
of reconstructed lumen and stent boundaries for further analysis in
the longitudinal dimension of the coronary artery. Our experiments over
OCT cross-sections taken from 7 patients presenting varying degrees of
NIH after PCI illustrate a good agreement between the computer method
and expert evaluations: Bland-Altmann analysis revealed a mean difference
for lumen cross-section area of 0.11 ± 0.70mm2 and for the stent
cross-section area of 0.10 ± 1.28mm2
Optical Coherence Tomography Angiography Vessel Density in Healthy, Glaucoma Suspect, and Glaucoma Eyes.
PurposeThe purpose of this study was to compare retinal nerve fiber layer (RNFL) thickness and optical coherence tomography angiography (OCT-A) retinal vasculature measurements in healthy, glaucoma suspect, and glaucoma patients.MethodsTwo hundred sixty-one eyes of 164 healthy, glaucoma suspect, and open-angle glaucoma (OAG) participants from the Diagnostic Innovations in Glaucoma Study with good quality OCT-A images were included. Retinal vasculature information was summarized as a vessel density map and as vessel density (%), which is the proportion of flowing vessel area over the total area evaluated. Two vessel density measurements extracted from the RNFL were analyzed: (1) circumpapillary vessel density (cpVD) measured in a 750-μm-wide elliptical annulus around the disc and (2) whole image vessel density (wiVD) measured over the entire image. Areas under the receiver operating characteristic curves (AUROC) were used to evaluate diagnostic accuracy.ResultsAge-adjusted mean vessel density was significantly lower in OAG eyes compared with glaucoma suspects and healthy eyes. (cpVD: 55.1 ± 7%, 60.3 ± 5%, and 64.2 ± 3%, respectively; P < 0.001; and wiVD: 46.2 ± 6%, 51.3 ± 5%, and 56.6 ± 3%, respectively; P < 0.001). For differentiating between glaucoma and healthy eyes, the age-adjusted AUROC was highest for wiVD (0.94), followed by RNFL thickness (0.92) and cpVD (0.83). The AUROCs for differentiating between healthy and glaucoma suspect eyes were highest for wiVD (0.70), followed by cpVD (0.65) and RNFL thickness (0.65).ConclusionsOptical coherence tomography angiography vessel density had similar diagnostic accuracy to RNFL thickness measurements for differentiating between healthy and glaucoma eyes. These results suggest that OCT-A measurements reflect damage to tissues relevant to the pathophysiology of OAG
Deep spectral learning for label-free optical imaging oximetry with uncertainty quantification
Measurement of blood oxygen saturation (sO2) by optical imaging oximetry provides invaluable insight into local tissue functions and metabolism. Despite different embodiments and modalities, all label-free optical-imaging oximetry techniques utilize the same principle of sO2-dependent spectral contrast from haemoglobin. Traditional approaches for quantifying sO2 often rely on analytical models that are fitted by the spectral measurements. These approaches in practice suffer from uncertainties due to biological variability, tissue geometry, light scattering, systemic spectral bias, and variations in the experimental conditions. Here, we propose a new data-driven approach, termed deep spectral learning (DSL), to achieve oximetry that is highly robust to experimental variations and, more importantly, able to provide uncertainty quantification for each sO2 prediction. To demonstrate the robustness and generalizability of DSL, we analyse data from two visible light optical coherence tomography (vis-OCT) setups across two separate in vivo experiments on rat retinas. Predictions made by DSL are highly adaptive to experimental variabilities as well as the depth-dependent backscattering spectra. Two neural-network-based models are tested and compared with the traditional least-squares fitting (LSF) method. The DSL-predicted sO2 shows significantly lower mean-square errors than those of the LSF. For the first time, we have demonstrated en face maps of retinal oximetry along with a pixel-wise confidence assessment. Our DSL overcomes several limitations of traditional approaches and provides a more flexible, robust, and reliable deep learning approach for in vivo non-invasive label-free optical oximetry.R01 CA224911 - NCI NIH HHS; R01 CA232015 - NCI NIH HHS; R01 NS108464 - NINDS NIH HHS; R21 EY029412 - NEI NIH HHSAccepted manuscrip
- …